Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia Registry and Prospective Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorChinese University of Hong Kong
About this trial
Since much is unknown about factors that lead to progression of the pre-neoplastic lesions and cancer. In addition, there is ongoing debate on the optimal surveillance intervals and techniques. To solve these important clinical questions, the establishment of a registry for a longitudinal study is planned.
Eligibility criteria
Qualifiers
Adults >= 18 years of age
Written informed consent obtained
Diagnosed with current or past H. pylori infection,
Histologically proven atrophic gastritis (body and/or antrum of stomach), intestinal metaplasia (complete and incomplete), dysplasia (any grade) and/or gastric cancer (post- treatment)
Disqualifiers
Co-morbid illness that prohibit endoscopic surveillance
Declines for study questionnaire, biobanking of specimens and/or regular review per study protocol
Trial design
Treatments tested in this trial
- Esophagogastroduodenoscopy
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov